ArticleHaematologica2022

Comment on: "Cardiovascular adverse events in patients with chronic lymphocytic leukemia receiving acalabrutinib monotherapy: pooled analysis of 762 patients".

Andrea Visentin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.